Back to Companies
Kairos Pharma, LTD.
KAPANYSECIK: 0001962011
Over the 7 most recent insider filings, Kairos Pharma, LTD. (KAPA) has seen activity from 7 distinct insiders — no open-market buying or selling. Samuelson Doug (Chief Financial Officer) is the most active by dollar volume. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$0
Purchases
$0
Sales
$0
Unique Insiders
7
Recent Insider Trades
7 loaded
| Nov 26 | KAPA Kairos Pharma, LTD. | Samuelson Doug | Chief Financial Officer | Grant | $0 |
| Nov 26 | KAPA Kairos Pharma, LTD. | Murali Ramachandran | VP of Research and Development | Grant | $0 |
| Dec 30 | KAPA Kairos Pharma, LTD. | Bhowmick Neil | Chief Scientific Officer | Grant | $0 |
| Nov 26 | KAPA Kairos Pharma, LTD. | Singhvi Rahul | Director | Grant | $0 |
| Nov 26 | KAPA Kairos Pharma, LTD. | Yu John S | CEO and Chairman, Director, 10% Owner | Grant | $0 |
| Dec 23 | KAPA Kairos Pharma, LTD. | Bae Hyun W. | Director | Grant | $0 |
| Nov 26 | KAPA Kairos Pharma, LTD. | Keyoung Hansoo Michael | Director | Grant | $0 |
7 filings